La maladie de Parkinson en France (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Eléments de l'association

Jean-Louis Montastruc18
Pharmacovigilance10
Jean-Louis Montastruc Sauf Pharmacovigilance" 11
Pharmacovigilance Sauf Jean-Louis Montastruc" 3
Jean-Louis Montastruc Et Pharmacovigilance 7
Jean-Louis Montastruc Ou Pharmacovigilance 21
Corpus2807
\n\n\n\n \n

List of bibliographic references

Number of relevant bibliographic references: 7.
Ident.Authors (with country if any)Title
000020 Santiago Perez-Lloret [France] ; María Ver Nica Rey [France] ; James Crispo [Canada] ; Daniel Krewski [Canada] ; Marise Lapeyre-Mestre [France] ; Jean-Louis Montastruc [France] ; Olivier Rascol [France]Risk of heart failure following treatment with dopamine agonists in Parkinson's disease patients
000351 Emmanuelle Bondon-Guitton [France] ; Santiago Perez-Lloret [France] ; Haleh Bagheri [France] ; Christine Brefel [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France]Drug-Induced Parkinsonism: A Review of 17 Years' Experience in a Regional Pharmacovigilance Center in France
000937 Jean-Louis Montastruc [France] ; Agnès Sommet [France] ; Pascale Olivier [France] ; Haieh Bagheri [France] ; Mireille Gony [France] ; Maryse Lapeyre-Mestre [France] ; Christine Brefel-Courbon [France] ; Joachim Ferreira [Portugal] ; Laurent Schmitt [France] ; Jean-Michel Senard [France] ; Olivier Rascol [France]Médicaments, maladie de Parkinson et syndromes parkinsoniens : actualités de pharmacovigilance
000B55 Atul Pathak [France] ; Valérie Raoul [France] ; Jean-Louis Montastruc [France] ; Jean-Michel Senard [France]Adverse drug reactions related to drugs used in orthostatic hypotension : a prospective and systematic pharmacovigilance study in France
000B75 Nhan Nguyen [France] ; Vincent Pradel [France] ; Joëlle Micallef [France] ; Jean-Louis Montastruc [France] ; Olivier Blin [France]Les syndromes parkinsoniens médicamenteux
000D45 Mireille Gony [France] ; Maryse Lapeyre-Mestre [France] ; Jean-Louis Montastruc [France]Risk of serious extrapyramidal symptoms in patients with Parkinson's disease receiving antidepressant drugs: A pharmacoepidemiologic study comparing serotonin reuptake inhibitors and other antidepressant drugs
001246 Jean-Louis Montastruc [France] ; Cathy Chaumerliac [France] ; Karine Desboeuf [France] ; Mimosa Manika [France] ; Haleh Bagheri [France] ; Olivier Rascol [France] ; Maryse Lapeyre-Mestre [France]Adverse drug reactions to selegiline : A review of the French Pharmacovigilance Database

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024